ICER Analyses Are Flawed, Undervalue Life-Saving Medicines, and Are Biased Toward Price Controls
PRI | Wayne Winegarden
March 17, 2021
A commonly-used analysis to determine a medicine’s value is based on flawed methodologies that would diminish innovation and access, finds a new report released today by the nonpartisan Center for Medical Economics and Innovation at the Pacific Research Institute.
“Cost effectiveness reports may provide precise estimates, but there is no reason to believe that these estimates accurately reflect the value of medicines,” said Dr. Wayne Winegarden, the brief’s author. “The documented biases in their value assessments should raise serious concerns that ICER’s work is inaccurate and biased toward undervaluing medicines.”
|
|
Healthcare Price Controls Don’t Come For Free
Forbes | Sally C. Pipes
March 16, 2021
But there’s no free lunch here. The consequences would be devastating. Medicare systematically underpays hospitals and doctor’s offices. In 2019, the program reimbursed hospitals 87 cents for every dollar of care consumed by Medicare patients, according to the American Hospital Association.
Read more. . .
|
|
‘Woke’ Science Has No Place in Government Policymaking
American Greatness | Andrew I. Fillat and Henry I. Miller
March 15, 2021
The “hard” sciences are a framework for understanding physical, chemical, subatomic, biological, and other natural or even man-made phenomena. The disciplines of physics, chemistry, biology, and especially mathematics, have nothing to do with society as such, because the phenomena they characterize exist independently of humans. Mathematics is typically the language of this framework, whether it is arcane calculus, probability theory, combinatorics, topology, or some other branch well understood by only a very select group.
|
|
Intellectual Property Rights Are Key To Fighting Covid-19 And Protecting Public Health
Real Clear Health and Forbes | Sally C. Pipes
March 11, 2021
As pharmaceutical researcher Derek Lowe has explained, “There are definitely not dozens of companies who can make enough RNA,” the genetic material in the Moderna and Pfizer/BioNTech vaccines that instructs our cells in how to fight the coronavirus. Lowe continues: “And you can count on one hand the number of facilities who can make the critical lipid nanoparticles” that carry the mRNA to our cells.
|
|
|
|
